Patients were treated using a GnRH agonist protocol with recombinant FSH @ IU/d and randomized from stimulation day @ to supplementation with hCG : D@ , @ IU/d ; D@ , @ IU/d ; D@ , @ IU/d ; and D@ , @ IU/d .